MedicationsMyBlueDotsStudy finds no elevated risk of thyroid cancer among GLP1-RA users MyBlueDots2 months ago01 mins A study has found no evidence that glucagon-like peptide 1 receptor agonist (GLP1-RA) use is associated with an increased risk of thyroid cancer. Go to Sourcehttps://medicalxpress.com/rss-feed/ Post navigation Previous: Survey shows previous experience affects family planning decisions of people with hereditary dementiaNext: Framework outlines steps for achieving health equity in stroke care
In the body, psilocybin becomes psilocin, which can increase nerve cell communication even in a single dose MyBlueDots1 day ago 0
FLIpping the switch: DNA regulator activates blood stem cells for improved transplantation success MyBlueDots1 day ago 0
Cryo-EM reveals hidden mechanics of DNA replication and sheds new light on cancer target MyBlueDots1 day ago 0